The Peripheral Arterial Disease (P.A.D.) Coalition presented its annual
Stay in Circulation Community Service Award to Parrish Medical Center,
Titusville, Fla, at the organization’s seventh annual meeting. The
Stay in Circulation Community Service Award recognizes collaborative programs
focused on increasing awareness about peripheral arterial disease to high-risk
populations, patients and/or the health care community.
Marialice Knight, RN, BSN, Parrish Medical Center cardiovascular community
RN and P.A.D. program coordinator accepted the award on the medical center’s behalf.
“Parrish Medical Center is extremely honored to receive this award,”
said Knight. “Our P.A.D. community program is a seven-year collaborative
effort of our hospital board of directors, administration, foundation,
staff members and our P.A.D. physicians. We are dedicated to the continued
support of the Coalition’s mission and to continue to identify individuals
with P.A.D. and assure they receive the same risk reduction and specific
treatment as those with coronary artery disease.”
Peripheral arterial disease occurs when arteries in the legs become narrowed
or clogged with fatty deposits, reducing blood flow to the legs. This
can result in leg muscle pain when walking, disability, amputation and
a poor quality of life. Blocked leg arteries found in people with P.A.D.
can be a warning sign that other arteries, including those in the heart
and brain, may also be affected—increasing the risk of a heart attack
Parrish Medical Center received the P.A.D. Community Service Award for
its innovative and comprehensive approach to P.A.D outreach and education.
The Center built a local P.A.D. network, a multidisciplinary collaborative
that served to educate the health care community and at risk individuals
about P.A.D. Since 2005, Parrish Medical Center has coordinated approximately
100 P.A.D. awareness presentations to hospital staff, local clinicians,
city employees and a variety of other audiences, and has completed nearly
2,500 P.A.D. screening tests for community members. The center was able
to accomplish this with seed money provided by the Jess Parrish Medical
Foundation to purchase P.A.D. screening equipment.
Community access to free, year round P.A.D. screenings provides a tool
to identify patients at risk for cardiovascular and peripheral arterial
disease. PMC has enhanced physician relationships with primary care, cardiology,
internal medicine and other subspecialties by assisting them in their
efforts to prevent and identify P.A.D. in their patient population. In
particular, a targeted partnership with 12 local physician practices has
proven to be a successful coordination of education, training and standardization
of practice for the detection and treatment of P.A.D. Media efforts have
supplemented all activities and successfully worked to further P.A.D.
messages within the community.
"On behalf of the P.A.D. Coalition, we are delighted to present the
third annual Community Service Award to Parrish Medical Center,"
said Marge Lovell, RN, Chair, P.A.D. Coalition and clinical trials nurse
at the London Health Sciences and Centre in London, Ontario. “Their
efforts serve as a model program to reach entire communities with P.A.D.
messages to help reduce the devastating consequences of the disease.”
For more information about P.A.D., visit www.P.A.D.coalition.org.
The P.A.D. Coalition The Peripheral Arterial Disease (P.A.D.) Coalition
is an international alliance of more than 80 North American and European
health organizations, professional societies, government agencies and
corporations united to improve the health and care of patients with P.A.D.
Established in 2004, the P.A.D. Coalition is a division of the Vascular
Disease Foundation (www.vdf.org), a national, not-for-profit section 501(c)(3)
organization. The P.A.D. Coalition is supported by the following national
sponsors: the Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership;
Cordis Endovascular, a division of Cordis Corporation; Abbott Vascular;
AstraZeneca; Bard Peripheral Vascular; BioMedix; Cook, Inc; ev3 Endovascular,
Inc.; W.L. Gore & Associates; Hokanson; PADTest; and Summit Doppler.